12-2651630-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The ENST00000344100.7(CACNA1C):c.4002C>T(p.Asp1334Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000459 in 1,613,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000085 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000042 ( 0 hom. )
Consequence
CACNA1C
ENST00000344100.7 synonymous
ENST00000344100.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.180
Publications
0 publications found
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
- Timothy syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizuresInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- long QT syndromeInheritance: AD Classification: MODERATE Submitted by: ClinGen
- long QT syndrome 8Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
- Brugada syndrome 3Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- short QT syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 12-2651630-C-T is Benign according to our data. Variant chr12-2651630-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 308149.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.18 with no splicing effect.
BS2
High AC in GnomAd4 at 13 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000344100.7 | c.4002C>T | p.Asp1334Asp | synonymous_variant | Exon 32 of 47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000399603.6 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 5 | NM_001167623.2 | ENSP00000382512.1 | |||
CACNA1C | ENST00000399655.6 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | NM_000719.7 | ENSP00000382563.1 | |||
CACNA1C | ENST00000682544.1 | c.4180-10C>T | intron_variant | Intron 33 of 49 | ENSP00000507184.1 | |||||
CACNA1C | ENST00000406454.8 | c.3946-10C>T | intron_variant | Intron 31 of 47 | 5 | ENSP00000385896.3 | ||||
CACNA1C | ENST00000399634.6 | c.3913-10C>T | intron_variant | Intron 30 of 46 | 5 | ENSP00000382542.2 | ||||
CACNA1C | ENST00000683824.1 | c.4111-10C>T | intron_variant | Intron 32 of 47 | ENSP00000507867.1 | |||||
CACNA1C | ENST00000347598.9 | c.4090-10C>T | intron_variant | Intron 33 of 48 | 1 | ENSP00000266376.6 | ||||
CACNA1C | ENST00000327702.12 | c.3946-10C>T | intron_variant | Intron 31 of 47 | 1 | ENSP00000329877.7 | ||||
CACNA1C | ENST00000399617.6 | c.3946-10C>T | intron_variant | Intron 31 of 47 | 5 | ENSP00000382526.1 | ||||
CACNA1C | ENST00000682462.1 | c.4036-10C>T | intron_variant | Intron 31 of 46 | ENSP00000507105.1 | |||||
CACNA1C | ENST00000683781.1 | c.4036-10C>T | intron_variant | Intron 31 of 46 | ENSP00000507434.1 | |||||
CACNA1C | ENST00000683840.1 | c.4036-10C>T | intron_variant | Intron 31 of 46 | ENSP00000507612.1 | |||||
CACNA1C | ENST00000683956.1 | c.4036-10C>T | intron_variant | Intron 31 of 46 | ENSP00000506882.1 | |||||
CACNA1C | ENST00000399638.5 | c.4030-10C>T | intron_variant | Intron 32 of 47 | 1 | ENSP00000382547.1 | ||||
CACNA1C | ENST00000335762.10 | c.4021-10C>T | intron_variant | Intron 32 of 47 | 5 | ENSP00000336982.5 | ||||
CACNA1C | ENST00000399606.5 | c.4006-10C>T | intron_variant | Intron 32 of 47 | 1 | ENSP00000382515.1 | ||||
CACNA1C | ENST00000399621.5 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382530.1 | ||||
CACNA1C | ENST00000399637.5 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382546.1 | ||||
CACNA1C | ENST00000402845.7 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000385724.3 | ||||
CACNA1C | ENST00000399629.5 | c.3997-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382537.1 | ||||
CACNA1C | ENST00000682336.1 | c.3988-10C>T | intron_variant | Intron 31 of 46 | ENSP00000507898.1 | |||||
CACNA1C | ENST00000399591.5 | c.3913-10C>T | intron_variant | Intron 30 of 45 | 1 | ENSP00000382500.1 | ||||
CACNA1C | ENST00000399595.5 | c.3913-10C>T | intron_variant | Intron 30 of 45 | 1 | ENSP00000382504.1 | ||||
CACNA1C | ENST00000399649.5 | c.3907-10C>T | intron_variant | Intron 30 of 45 | 1 | ENSP00000382557.1 | ||||
CACNA1C | ENST00000399597.5 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382506.1 | ||||
CACNA1C | ENST00000399601.5 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382510.1 | ||||
CACNA1C | ENST00000399641.6 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382549.1 | ||||
CACNA1C | ENST00000399644.5 | c.3946-10C>T | intron_variant | Intron 31 of 46 | 1 | ENSP00000382552.1 | ||||
CACNA1C | ENST00000682835.1 | c.3946-10C>T | intron_variant | Intron 31 of 46 | ENSP00000507282.1 | |||||
CACNA1C | ENST00000683482.1 | c.3937-10C>T | intron_variant | Intron 31 of 46 | ENSP00000507169.1 | |||||
CACNA1C | ENST00000682686.1 | c.3913-10C>T | intron_variant | Intron 30 of 45 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
13
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000481 AC: 12AN: 249314 AF XY: 0.0000370 show subpopulations
GnomAD2 exomes
AF:
AC:
12
AN:
249314
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461666Hom.: 0 Cov.: 33 AF XY: 0.0000413 AC XY: 30AN XY: 727130 show subpopulations
GnomAD4 exome
AF:
AC:
61
AN:
1461666
Hom.:
Cov.:
33
AF XY:
AC XY:
30
AN XY:
727130
show subpopulations
African (AFR)
AF:
AC:
9
AN:
33480
American (AMR)
AF:
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
11
AN:
26134
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
AC:
0
AN:
53392
Middle Eastern (MID)
AF:
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
36
AN:
1111838
Other (OTH)
AF:
AC:
4
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74330 show subpopulations
GnomAD4 genome
AF:
AC:
13
AN:
152150
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74330
show subpopulations
African (AFR)
AF:
AC:
13
AN:
41428
American (AMR)
AF:
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68010
Other (OTH)
AF:
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Long QT syndrome Benign:1
Dec 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.